Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion type Assertion NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_head.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion description "[Among the genes used in our marker panel, KS1/4 appears particularly useful for the detection of overt or occult metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_provenance.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion evidence source_evidence_literature NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_provenance.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion SIO_000772 15705978 NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_provenance.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion wasDerivedFrom befree-20140225 NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_provenance.
- NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_assertion wasGeneratedBy ECO_0000203 NP542579.RAHXvoth9MqZLd24lYg_KD4XgYG4LcMQ8HNUzyArCPrto130_provenance.